nontargeting shrna Search Results


93
Addgene inc nontargeting shrna
Nontargeting Shrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Lentiviral+nontargeting+shRNA+GFP+(Plasmid+%23155285)/pmc06597881-387-27-37
Average 93 stars, based on 1 article reviews
nontargeting shrna - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Shanghai GenePharma control nontargeting shrna
Control Nontargeting Shrna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/control+nontargeting+shrna++shnt+/pmc04858956-55-14-21
Average 90 stars, based on 1 article reviews
control nontargeting shrna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cellecta Inc nontarget shrna
Nontarget Shrna, supplied by Cellecta Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/nontarget+shrna/pmc07494916-309-15-11
Average 90 stars, based on 1 article reviews
nontarget shrna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma nontarget control shrna
Nontarget Control Shrna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/nontarget+control+shrna/pm39103915-80-7-13
Average 90 stars, based on 1 article reviews
nontarget control shrna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Vigene Biosciences shrnas targeting mouse ncl mrna and nontargeting control shrna (shctrl)
Shrnas Targeting Mouse Ncl Mrna And Nontargeting Control Shrna (Shctrl), supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/shrnas+targeting+mouse+ncl+mrna+and+nontargeting+control+shrna++shctrl+/10__1128_slash_jvi__00238___21-390-1-18
Average 90 stars, based on 1 article reviews
shrnas targeting mouse ncl mrna and nontargeting control shrna (shctrl) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma shrna against nontarget nt
Overexpression or knockdown <t>of</t> <t>Piwil1</t> in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with <t>shRNA</t> against Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. ( b and c ) RT-qPCR and western blot demonstrated expression level of Piwil1 in Ishikawa, Ishikawa NT and Ishikawa shPiwil1 cells or HEC-1B, HEC-1B EV and HEC-1B exPiwil1 cells (* P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in Ishikawa NT and Ishikawa shPiwil1 cells or in HEC-1B EV and HEC-1B exPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm
Shrna Against Nontarget Nt, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/shrna+against+nontarget+nt/pmc04624602-83-17-21
Average 90 stars, based on 1 article reviews
shrna against nontarget nt - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Transomic Technologies Inc nontargeting control shrna
Overexpression or knockdown <t>of</t> <t>Piwil1</t> in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with <t>shRNA</t> against Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. ( b and c ) RT-qPCR and western blot demonstrated expression level of Piwil1 in Ishikawa, Ishikawa NT and Ishikawa shPiwil1 cells or HEC-1B, HEC-1B EV and HEC-1B exPiwil1 cells (* P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in Ishikawa NT and Ishikawa shPiwil1 cells or in HEC-1B EV and HEC-1B exPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm
Nontargeting Control Shrna, supplied by Transomic Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/nontargeting+control+shrna/pm30061105-263-9-16
Average 90 stars, based on 1 article reviews
nontargeting control shrna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ribobio co nontarget shrnas
Overexpression or knockdown <t>of</t> <t>Piwil1</t> in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with <t>shRNA</t> against Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. ( b and c ) RT-qPCR and western blot demonstrated expression level of Piwil1 in Ishikawa, Ishikawa NT and Ishikawa shPiwil1 cells or HEC-1B, HEC-1B EV and HEC-1B exPiwil1 cells (* P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in Ishikawa NT and Ishikawa shPiwil1 cells or in HEC-1B EV and HEC-1B exPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm
Nontarget Shrnas, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/nontarget+shrnas/pm36473706-52-8-29
Average 90 stars, based on 1 article reviews
nontarget shrnas - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma nontargeted scrambled control shrna–nc
Overexpression or knockdown <t>of</t> <t>Piwil1</t> in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with <t>shRNA</t> against Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. ( b and c ) RT-qPCR and western blot demonstrated expression level of Piwil1 in Ishikawa, Ishikawa NT and Ishikawa shPiwil1 cells or HEC-1B, HEC-1B EV and HEC-1B exPiwil1 cells (* P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in Ishikawa NT and Ishikawa shPiwil1 cells or in HEC-1B EV and HEC-1B exPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm
Nontargeted Scrambled Control Shrna–Nc, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/nontargeted+scrambled+control+shrna+nc/pm36335462-11-14-21
Average 90 stars, based on 1 article reviews
nontargeted scrambled control shrna–nc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Xeragon Inc nontargeting shrna 5'-uucuccgaacgugucacgu-3
GH-induced expression of early response genes is impaired by C/EBPβ deficiency. A, Pooled C/EBPβ-deficient 3T3-F442A preadipocytes expressing shβ, or control sh-C cells, were treated without (open bar) or with GH (black bar) for 30 min. RNA was analyzed by qPCR as for Fig. 1. Each bar shows the mean ± se for three independent experiments. mRNA expression in sh-C cells with GH treatment is set equal to 1. The response to GH in shβ cells is significantly (P < 0.01) less than the response in sh-C cells as indicated by brackets. B, Endogenous C/EBPβ protein, shown by immunoblot, is almost completely deficient in 3T3-F442A preadipocytes stably expressing shβ, clones 1 and 2 (lanes 3 and 4), compared with control cells expressing <t>nontargeting</t> <t>shRNA</t> (sh-C, lane 2) or noninfected parental 3T3-F442A cells (−, lane 1). Tubulin (lower panel) indicates sample loading. The shβ1 cells were used in A and in subsequent experiments.
Nontargeting Shrna 5' Uucuccgaacgugucacgu 3, supplied by Xeragon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/nontargeting+shrna+5++uucuccgaacgugucacgu+3/pmc03063086-413-10-13
Average 90 stars, based on 1 article reviews
nontargeting shrna 5'-uucuccgaacgugucacgu-3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Genechem padtrack-cmvgfp carrying either short hairpin rna (shrna) targeting pkca (ad-pkca-shrna) or the nontargeting random sequence
GH-induced expression of early response genes is impaired by C/EBPβ deficiency. A, Pooled C/EBPβ-deficient 3T3-F442A preadipocytes expressing shβ, or control sh-C cells, were treated without (open bar) or with GH (black bar) for 30 min. RNA was analyzed by qPCR as for Fig. 1. Each bar shows the mean ± se for three independent experiments. mRNA expression in sh-C cells with GH treatment is set equal to 1. The response to GH in shβ cells is significantly (P < 0.01) less than the response in sh-C cells as indicated by brackets. B, Endogenous C/EBPβ protein, shown by immunoblot, is almost completely deficient in 3T3-F442A preadipocytes stably expressing shβ, clones 1 and 2 (lanes 3 and 4), compared with control cells expressing <t>nontargeting</t> <t>shRNA</t> (sh-C, lane 2) or noninfected parental 3T3-F442A cells (−, lane 1). Tubulin (lower panel) indicates sample loading. The shβ1 cells were used in A and in subsequent experiments.
Padtrack Cmvgfp Carrying Either Short Hairpin Rna (Shrna) Targeting Pkca (Ad Pkca Shrna) Or The Nontargeting Random Sequence, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/padtrack+cmvgfp+carrying+either+short+hairpin+rna++shrna++targeting+pkca++ad+pkca+shrna++or+the+nontargeting+random+sequence/pm29648633-62-0-25
Average 90 stars, based on 1 article reviews
padtrack-cmvgfp carrying either short hairpin rna (shrna) targeting pkca (ad-pkca-shrna) or the nontargeting random sequence - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation control nontargeting shrna
GH-induced expression of early response genes is impaired by C/EBPβ deficiency. A, Pooled C/EBPβ-deficient 3T3-F442A preadipocytes expressing shβ, or control sh-C cells, were treated without (open bar) or with GH (black bar) for 30 min. RNA was analyzed by qPCR as for Fig. 1. Each bar shows the mean ± se for three independent experiments. mRNA expression in sh-C cells with GH treatment is set equal to 1. The response to GH in shβ cells is significantly (P < 0.01) less than the response in sh-C cells as indicated by brackets. B, Endogenous C/EBPβ protein, shown by immunoblot, is almost completely deficient in 3T3-F442A preadipocytes stably expressing shβ, clones 1 and 2 (lanes 3 and 4), compared with control cells expressing <t>nontargeting</t> <t>shRNA</t> (sh-C, lane 2) or noninfected parental 3T3-F442A cells (−, lane 1). Tubulin (lower panel) indicates sample loading. The shβ1 cells were used in A and in subsequent experiments.
Control Nontargeting Shrna, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/control+nontargeting+shrna/pm32203497-292-1-6
Average 90 stars, based on 1 article reviews
control nontargeting shrna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Overexpression or knockdown of Piwil1 in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with shRNA against Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. ( b and c ) RT-qPCR and western blot demonstrated expression level of Piwil1 in Ishikawa, Ishikawa NT and Ishikawa shPiwil1 cells or HEC-1B, HEC-1B EV and HEC-1B exPiwil1 cells (* P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in Ishikawa NT and Ishikawa shPiwil1 cells or in HEC-1B EV and HEC-1B exPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm

Journal: BMC Cancer

Article Title: Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition

doi: 10.1186/s12885-015-1794-8

Figure Lengend Snippet: Overexpression or knockdown of Piwil1 in human endometrial cancer cell lines. a Stable transfection of Ishikawa cells with shRNA against Piwil1 and HEC-1B cells with Piwil1 expression plasmids. The percentage of transfected cells with fluorescence was > 95 %. ( b and c ) RT-qPCR and western blot demonstrated expression level of Piwil1 in Ishikawa, Ishikawa NT and Ishikawa shPiwil1 cells or HEC-1B, HEC-1B EV and HEC-1B exPiwil1 cells (* P < 0.05). d Representative immunofluorescence images showing Piwil1 expression in Ishikawa NT and Ishikawa shPiwil1 cells or in HEC-1B EV and HEC-1B exPiwil1 cells. Nuclei were stained with DAPI. Scale bars, 25 μm

Article Snippet: Ishikawa cells were transfected with shRNA against Piwil1 (shPiwil1, Genepharma) (sense: 5’-AGTCAGCAACCTGGTTATA-3’; antisense: 5’- TATAACCAGGTTGCTGACTGG -3’) or shRNA against nontarget (NT, Genepharma) by LipofectamineTM 2000.

Techniques: Over Expression, Knockdown, Stable Transfection, shRNA, Expressing, Transfection, Fluorescence, Quantitative RT-PCR, Western Blot, Immunofluorescence, Staining

GH-induced expression of early response genes is impaired by C/EBPβ deficiency. A, Pooled C/EBPβ-deficient 3T3-F442A preadipocytes expressing shβ, or control sh-C cells, were treated without (open bar) or with GH (black bar) for 30 min. RNA was analyzed by qPCR as for Fig. 1. Each bar shows the mean ± se for three independent experiments. mRNA expression in sh-C cells with GH treatment is set equal to 1. The response to GH in shβ cells is significantly (P < 0.01) less than the response in sh-C cells as indicated by brackets. B, Endogenous C/EBPβ protein, shown by immunoblot, is almost completely deficient in 3T3-F442A preadipocytes stably expressing shβ, clones 1 and 2 (lanes 3 and 4), compared with control cells expressing nontargeting shRNA (sh-C, lane 2) or noninfected parental 3T3-F442A cells (−, lane 1). Tubulin (lower panel) indicates sample loading. The shβ1 cells were used in A and in subsequent experiments.

Journal: Molecular Endocrinology

Article Title: C/EBP? Mediates Growth Hormone-Regulated Expression of Multiple Target Genes

doi: 10.1210/me.2010-0232

Figure Lengend Snippet: GH-induced expression of early response genes is impaired by C/EBPβ deficiency. A, Pooled C/EBPβ-deficient 3T3-F442A preadipocytes expressing shβ, or control sh-C cells, were treated without (open bar) or with GH (black bar) for 30 min. RNA was analyzed by qPCR as for Fig. 1. Each bar shows the mean ± se for three independent experiments. mRNA expression in sh-C cells with GH treatment is set equal to 1. The response to GH in shβ cells is significantly (P < 0.01) less than the response in sh-C cells as indicated by brackets. B, Endogenous C/EBPβ protein, shown by immunoblot, is almost completely deficient in 3T3-F442A preadipocytes stably expressing shβ, clones 1 and 2 (lanes 3 and 4), compared with control cells expressing nontargeting shRNA (sh-C, lane 2) or noninfected parental 3T3-F442A cells (−, lane 1). Tubulin (lower panel) indicates sample loading. The shβ1 cells were used in A and in subsequent experiments.

Article Snippet: The shRNA control 3T3-F442A preadipocytes (designated sh-C) stably expressing a nontargeting shRNA (5′-UUCUCCGAACGUGUCACGU-3′) (QIAGEN-Xeragon, Germantown, MD) have been described ( 68 ).

Techniques: Expressing, Control, Western Blot, Stable Transfection, Clone Assay, shRNA